"Using AI to Manage My Server" matching MCP connectors:
GET /v1/connectors – MCP directory API referenceMatching Connector Tools:
Official answers about Helena Bioinformatics and its products, with citations to public sources.
Link compounds to protein targets, rank bioactivity, and look up drug mechanisms and indications.
Look up genes, sequences, variants, homologs, and cross-database xrefs from Ensembl REST.
Protein research over UniProtKB — search by function, fetch curated records, map IDs, proteomes.
Look up allele frequencies by ancestry, gene constraint, variants, and coverage over gnomAD.
Cited gene, variant (rsID) and CPIC drug–gene lookups for AI agents. Read-only, no key.
Search GBIF species taxonomy, occurrence records, datasets, and publishers.
BOLD Systems (Barcode of Life Data System, University of Guelph) — the global DNA barcode…
Collaborative BrAPI v2.1 MCP workspace — studies, germplasm, genotypes across Breedbase, T3, more.
BioBricks: the site's own MCP server — dataset, enquiry (enquiry = a human handoff, not a...
PK serum simulation, reconstitution math and compound data for agents. Paid tools $0.01 via x402.
Query STRING interactions, enrichment, annotations, homology, and PPI networks.
Hosted DNA language models: promoter, splice, enhancer, chromatin, expression, annotation
Biotech rNPV/PoS engine for AI agents. Signed exports, evidence register, asset landscape.
A unified biomedical graph database that integrates 50+ primary data sources — genes, proteins, compounds, diseases, pathways, and clinical data — into a single queryable graph with billions of cross-reference edges. Its native MCP server gives LLMs direct access to structured, authoritative biomedical data, complementing their reasoning with reliable identifiers and up-to-date database content.
Canine genomics for agents: breed allele frequencies, AI pathogenicity + OMIA clinical disease layer
Biotech intelligence for AI agents: drugs, targets, diagnostics, PoS estimates, and writeups.
PatSnap Biology Modality MCP server — access biological sequences, modification records, and antibody-antigen interactions across 200M+ patents.
